Market Challenges And Opportunities

However, acrylamide is classified as an extremely hazardous substance in the U.S. The International Agency for Research on Cancer classifies acrylamide as a Group 2A carcinogen. Moreover, several substitutes are available for methylene bisacrylamide. These factors are expected to hinder growth of the market over the forecast period.

The increasing demand for stable copolymers and composites is expected offer lucrative growth opportunities for players in the market. Moreover, stability and versatility of methylene bisacrylamide in majority of polymerization reactions related to acrylonitrile is expected to increase its preference over other alternatives, thereby contributing to the market growth.